| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEWR | Common Stock | Options Exercise | $507,900 | +30,000 | $16.93* | 30,000 | 03 Jan 2022 | Direct | ||
| transaction | NEWR | Common Stock | Sale | $1,023,590 | -9,683 | -32% | $105.71 | 20,317 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | NEWR | Common Stock | Sale | $1,546,932 | -14,517 | -71% | $106.56 | 5,800 | 03 Jan 2022 | Direct | F1, F3 |
| transaction | NEWR | Common Stock | Sale | $558,480 | -5,200 | -90% | $107.40 | 600 | 03 Jan 2022 | Direct | F1, F4 |
| transaction | NEWR | Common Stock | Sale | $32,577 | -300 | -50% | $108.59 | 300 | 03 Jan 2022 | Direct | F1, F5 |
| transaction | NEWR | Common Stock | Sale | $33,012 | -300 | -100% | $110.04 | 0 | 03 Jan 2022 | Direct | F1, F6 |
| transaction | NEWR | Common Stock | Sale | $676,438 | -6,399 | -0.12% | $105.71 | 5,481,257 | 03 Jan 2022 | By Trust | F1, F2, F7 |
| transaction | NEWR | Common Stock | Sale | $1,044,591 | -9,801 | -0.18% | $106.58 | 5,471,456 | 03 Jan 2022 | By Trust | F1, F7, F8 |
| transaction | NEWR | Common Stock | Sale | $365,092 | -3,400 | -0.06% | $107.38 | 5,468,056 | 03 Jan 2022 | By Trust | F1, F7, F9 |
| transaction | NEWR | Common Stock | Sale | $21,710 | -200 | -0% | $108.55 | 5,467,856 | 03 Jan 2022 | By Trust | F1, F7, F10 |
| transaction | NEWR | Common Stock | Sale | $22,012 | -200 | -0% | $110.06 | 5,467,656 | 03 Jan 2022 | By Trust | F1, F6, F7 |
| holding | NEWR | Common Stock | 274,000 | 03 Jan 2022 | By Trust | F11 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NEWR | Stock Option (Right to Buy) | Options Exercise | $0 | -30,000 | -7.8% | $0.000000 | 355,000 | 03 Jan 2022 | Common Stock | 30,000 | $16.93 | Direct | F12 |
| Id | Content |
|---|---|
| F1 | Shares sold pursuant to a 10b5-1 plan. |
| F2 | The shares were sold at prices ranging from $105.10 to $106.095. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The shares were sold at prices ranging from $106.10 to $107.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | The shares were sold at prices ranging from $107.12 to $108.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | The shares were sold at prices ranging from $108.24 to $109.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F6 | The shares were sold at prices ranging from $110.01 to $110.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Shares are held directly by Lewis Cirne and Kirsten L. Vliet, as Trustees of the Cirne Family Revocable Trust UAD March 20, 2012. |
| F8 | The shares were sold at prices ranging from $106.12 to $107.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F9 | The shares were sold at prices ranging from $107.13 to $107.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F10 | The shares were sold at prices ranging from $108.25 to $108.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F11 | The shares are held directly by J.P. Morgan Trust Company of Delaware, as Trustee of the Cirne Family 2012 Irrevocable Trust. |
| F12 | Fully vested and exercisable. |